HOME >> BIOLOGY >> NEWS
Plant-Based Therapies Examined For Colon Cancer Prevention

Three therapies derived from plants will be tested at The Rockefeller University in New York City for their ability to prevent colorectal cancer, which afflicts some 150,000 Americans each year. The compounds have the potential to be safer than cancer-thwarting nonsteroidal antiinflammatory drugs (NSAIDs), widely used aspirin-like drugs known to prevent colorectal cancer as well as reduce related deaths by half.

Eating diets rich in fruits and vegetables helps reduce the risk of colorectal cancer as well as deaths from the disease, according to population-based studies. However, the chemicals in these plants responsible for the anti-cancer effect are not well known. "Certain plant-derived compounds called phenolics act similarly to NSAIDs in hindering cancer, yet may lack their bad side effects such as irritating the stomach lining or damaging the liver or kidneys," says Steven J. Shiff, M.D., assistant professor in the Laboratory of Human Behavior and Metabolism at Rockefeller. "If as effective or better than the drugs, these plant therapies might be much better tolerated for longer periods of time than NSAIDs."

In the study, Shiff and his colleagues will compare three plant-derived compounds, curcumin, rutin and quercetin, to the NSAID sulindac. The study will determine whether these naturally occuring chemicals, all potent antioxidants and antiinflammatories, can affect cells in a similar manner as sulindac, which prompts the cells to "turn on" a program of regulated cell death called apoptosis. NSAIDs, which include ibuprofen and naproxen, are among the most commonly used therapies worldwide for relieving pain and inflammation in joints and muscles.

Curcumin, notes Shiff, has been used for centuries as an antiinflammatory agent. The compound is the pigment that gives the yellow color to the seasoning curry, mustard and turmeric, the powdered form of the root of Curcuma longa Linn. Curcumin is an approved additi
'"/>

Contact: Marion E. Glick or Joseph Bonner
runews@rockvax.rockefeller.edu
212-327-7900
Rockefeller University
24-Sep-1997


Page: 1 2 3

Related biology news :

1. Plant-Based Fat Inhibits Growth Of Breast-Cancer Cell Line, UB Researchers Show
2. Plant-Based Fat May Reduce Risk Of Prostate Cancer By Altering Testosterone Metabolism, UB Study Shows
3. Plant-Based Fat Inhibits Cancer-Cell Growth By Enhancing Cells Signaling System, UB Researchers Show
4. Image-guided Therapies
5. New Anti-HIV Therapies Needed To Eradicate HIV
6. UCSF Team Identifies Two Key Molecules In Asthma; Important Finding For New Therapies That Treat Disease At Cell Level
7. Genetically Engineered Mice Show Characteristic Signs Of Alzheimers, Could Be Ideal Tool For Testing New Therapies
8. Penn Researchers Prove "Short-Cut" Function Of Myelin Sheath Channel: BetterUnderstanding Of Myelin Should Lead To Therapies For Neuropathies
9. New Insights On Sequence of Cell Death After Brain Injury: Understanding Cellular Events After Brain Trauma Could Lead To Better Therapies
10. Harvard Medical School Researchers Identify Four Human Genes Essential To Cell Division; Discovery Yields New Target For Cancer Therapies
11. Novel AIDS-Directed Technology: Approach Permits Optimization Of Existing Drug Therapies And Targeted, Patient-Specific Treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... ... 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host ... by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, ...
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, a ... purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture ... facility located in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... biopharmaceutical R&D, today announced that it has entered into a multi-year contract ... (Multiclonics®), to support their translational and clinical research strategy to discover and ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 08, 2020 , ... Bode Technology, a ... laboratory operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume ... Bode-CARES provides a turnkey solution that includes a comprehensive collection and virus-management ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, ... the hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. ... of Sentien’s lead product, SBI-101. Dr. Nissenson serves as an Emeritus Professor ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... of 40% in 2020, despite many obstacles created as a result of COVID-19. ... revenue for its partnered medical practices and medical manufacturers by expanding access to ...
(Date:6/28/2020)... ... ... The Indoor Lab, a leading provider of sensor solutions for monitoring foot ... ensure cleanliness, distancing and occupancy with its patent pending WipeAway™ technology using Artificial Intelligence ... a health performance index system that scores all aspects of compliance similar to the ...
Breaking Biology Technology:
Cached News: